Coronary Stents Market
Coronary Stents Market by Product, Raw Material, End User & Regional | Forecast 2022 to 2032
Substantial Rise in the Heart Diseases and Minimally Invasive Procedures is expected to Continue Boosting the Market
Coronary Stents Market Snapshot (2022 to 2032)
As per the latest Future Market Insights (FMI) analysis, demand for coronary stents and portable coronary stents will rise exponentially in the coming years. An aging population and a rising prevalence of risk factors such as cardiovascular diseases (CVDs), complex lesions, diabetes, obesity, and others are expected to drive demand for coronary stents over the forecast period.
Added advantages of stenting procedures include substantial improvement of blood flow and prevention of further damage to the heart muscle. It also helps in improving the symptoms of heart disease, such as angina and shortness of breath thereby, reducing the need for coronary bypass surgery. Thus, surgeons prefer stenting, as it is a minimally invasive procedure and post-operative recovery is relatively fast.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Coronary Stents Demand Analysis (2016 to 2021) Vs Market Outlook (2022 to 2032)
According to the WHO, in 2019, CVDs were among the major causes of mortality worldwide. In 2019, an estimated 17.9 million people died from CVDs, responsible for 32% of all worldwide mortalities. The global Coronary Stents market is expected to grow at a significant CAGR between 2022 and 2032, in comparison to the 7% CAGR registered from 2016 to 2021.
Furthermore, according to research published in the National Library of Medicine in June 2021, one of the CVDs, coronary artery disease (CAD), causes roughly 610,000 fatalities yearly (an estimated 1 in 4 deaths) and is the major cause of mortality in the USA. As a result, the unprecedented rise in CAD incidence is predicted to boost demand for an effective coronary stent device for treatment. This factor is expected to bolster the demand throughout the forecast period.
Which Drivers Underpin Coronary Stents Industry Expansion?
Increasing Prevalence of Obesity Likely to Augment the Overall Demand
The increasing global aging population is resulting in an increasing patient pool with major cardiovascular diseases. Also, hypertension is emerging as a major public health concern. Aged individuals are more prone to various cardiovascular diseases due to high total serum cholesterol levels.
Also, obesity is one of the major risk factors responsible for various cardiovascular diseases worldwide. Excessive weight or obesity causes abnormal or excessive accumulation of fats inside the artery lumen that causes several health problems such as coronary heart diseases. Hence, weight loss and obesity management are integral parameters to avoid any kind of cardiovascular disease.
According to WHO estimates, each year, 2.8 million deaths across the globe are due to diseases caused by obesity. Thus, the increasing aging and obese population are major factors expected to fuel the growth of the global coronary stents market over the forecast period.
Increasing the Number of Stenting Procedures to Push the Sales
Added advantages of stenting procedures include substantial improvement of blood flow and prevention of further damage to the heart muscle. Patients suffering from coronary artery blockage are prescribed coronary stenting. Angioplasty is the first line of treatment for patients suffering from acute coronary artery blockages. The number of patients undergoing stenting has been increasing steadily over the last decade. This is due to the emergence of outpatient coronary stenting procedures, which reduces long hospital stays. Further, the usage of bioabsorbable coronary scaffolds in coronary blockage has proven more beneficial over drug-eluting stents.
Therefore, an increasing number of cardiologists referring to stenting procedures for patients suffering from CAD is a major factor expected to fuel revenue growth of the coronary stents market in the near future.
Find your sweet spots for generating winning opportunities in this market.
Which Factors are limiting the Growth of the Coronary Stents Market?
Some of the leading factors limiting the growth of the market include-
- Availability of Alternative Treatment Methods for Coronary Artery Disease
- Stringent Regulations for Product Approval
- Product Failure and Product Recalls
- Complications Associated With Implantation of Stents
- Declining Costs of Stents
USA is Dominating the Coronary Stents Market by Growing Prevalence of Coronary Artery Diseases
The North American region dominates the coronary stents market share by securing the maximum share during the forecast period. The USA is leading the market size due to the growing number of heart diseases and the rising patient who has CAD during the forecast period. However, the rising adoption of angioplasty among patients is increasing the all-over production of coronary stents, which increases the USA coronary stents market share.
According to National Center for Health Statistics, every year, 1 in 4 deaths in the USA are caused due to coronary artery disease (CAD). Approximately 785,000 people in the USA suffer from their first heart attack, and 470,000 suffer from myocardial infarction. In addition, due to changing lifestyle habits, smoking and pollution are increasing the prevalence of coronary artery diseases in the USA in recent years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
United Kingdom Market for Coronary Stents Drives by Growing Healthcare Sector
The Europe region is capturing a significant market share due to rising government initiatives during the forecast period. The United Kingdom
coronary stents market is a prominent leader that contributes a significant share in the region by conducting new initiatives and investing in the healthcare sector during the forecast period. The key manufacturers have increased the United Kingdom
coronary stents market size by innovating advanced technology tools to treat patients efficiently in recent years. Moreover, the innovation of the PCI procedure is advanced and most accepted by the healthcare sector in the USA during the forecast period. In addition, this procedure helps to improve survivability and lower chest pain.
Korea Coronary Stents Market Boost by Growing Medical Infrastructure
The Asia Pacific coronary stents market is one of the fastest-growing regions during the forecast period capturing a high CAGR. Korea is one of the leading countries that increase the coronary stents market growth by growing medical infrastructure during the foreseen time. The manufacturers in Korea have been developing expensive medical devices and innovating as per end-users' demands to acquire maximum output in recent years. Moreover, these players are launching high-value medical consumables devices for the effective treatment of coronary disease patients, which is likely to increase the Korean coronary stents market size.
Japan Market for Coronary Stents Drives by Rising Awareness Related Coronary Treatment
Japan is another country in the Asia Pacific region that also capture the maximum share in the region during the forecast period. Rising awareness related to coronary treatment and the dropping price of coronary stents increased the Japan coronary stents market growth during the forecast period. Moreover, the Growing sedentary lifestyle and growing management of the disease are surging the demand for coronary stents in Japan during the forecast period. In addition, the growing center for cardiac disease and rising coronary stent implantation are flourishing the Japanese coronary stents market growth in recent years.
Country-wise Insights
How big is the Opportunity in the USA?
The increasing prevalence of coronary artery diseases (CAD) is likely to augment the market growth
The increasing prevalence of coronary artery disease is fuelling the demand for interventional cardiology treatment in the USA. Patients suffering from long-term CAD are opting for angioplasty as the first line of treatment.
According to National Center for Health Statistics, every year 1 in 4 deaths in the USA are caused due to coronary artery diseases (CAD) and approximately 785,000 people in the USA suffer from their first heart attack and 470,000 suffer from myocardial infarction.
This is due to changing lifestyle habits, smoking, pollution, and other factors. This increasing prevalence of coronary artery diseases and higher healthcare expenditure in lower-middle-income countries is projected to boost the growth of the global coronary stents market over the forecast period.
How Lucrative Are Opportunities in China?
Favorable Government Support for Healthcare Development to Push the Market Positively
Increased government investment in healthcare and conducting new initiatives to bring in devices at affordable prices in cost constraint markets such as China are influencing this market as well.
For instance, in China, to address inflated pricing and other issues in the delivery of expensive medical supplies, the Chinese government launched a centralized procurement scheme for high-value medical consumables in January 2021.
The government aims to use this initiative to skip the associated suppliers and buy the items straight from the manufacturers, lowering the inflated pricing. As a result, the cost of coronary stents has dropped dramatically in China. The average price of coronary stents has been reduced by 93 % since 2019 to grab the national tender.
Start-ups for Coronary Stents Market
Some key startups in the Coronary Stents market include-
- Silk Road Medical produces devices for Transcarotid artery revascularization (TAR) procedures for carotid artery disease. Their products include the EnRoute Transcarotid Neuroprotection and the EnRoute Stent system. The ENROUTE Transcarotid Stent is intended to be used in conjunction with the Transcarotid Neuroprotection System (NPS) during the TCAR procedure. A small incision is made just above the collar bone to expose the common carotid artery in which a flexible sheath is placed directly into the carotid artery and connected to a system that will reverse the flow of blood away from the brain to protect against fragments of plaque.
- Echopoint Medical is a leading developer of smart devices for monitoring coronary artery disease and microvascular dysfunction. The company is involved in the development of optical-fiber-based sensors that integrate into medical devices for monitoring cardiac health. It has developed its microcatheter device that uses nanomaterials and sensors that can be positioned into cardiovascular devices for detecting heart conditions by using iKOR technology.
Who are the Leading Players in the Coronary Stents Market?
The top Coronary Stents market players are constantly upgrading their offerings to help end users. They are investing in partnerships, acquisitions, collaborations, and new product launches to gain a competitive edge in the market. For instance:
- In April 2021, Abbott announced the launch of the coronary imaging platform Ultreon 1.0 Software powered by Al in Europe. The software has been launched with the aim to improve the detection of calcium-based blockages and measuring vessel diameter during coronary stenting procedures.
- In February 2021, Cardiovascular Systems Inc announced a partnership agreement with Chansu Vascular Technologies, LLC with an aim to develop peripheral and coronary drug-coated balloons for applications in drug-eluting stents.
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 5.1% from 2022 to 2032 |
|
Market Value in 2022 |
US$ 33.36 Million |
|
Market Value in 2032 |
US$ 51.2 Million |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2016 to 2021 |
|
Forecast Period |
2022 to 2032 |
|
Quantitative Units |
Revenue in US$ Million and CAGR from 2022 to 2032 |
|
Report Coverage |
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
Key Segments Covered in the Coronary Stents Industry Analysis
By Product:
- Drug Eluting Stent (DES)
- Bare Metal Stent (BMS)
- Bioresorbable Vascular Stent (BVS)
By Raw Material:
- Cobalt-Chromium
- Stainless Steel
- Platinum – Chromium
- Nickel – Titanium
- Polymer
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
By Region:
- North America
- Latin America
- Brazil
- Western Europe
- Eastern Europe
- Asia Pacific Excluding Japan
- Japan
- Middle East and Africa (MEA)
Frequently Asked Questions
What is the expected market value for Coronary Stents in 2022?
As of 2022, the Coronary Stents market is slated to reach a valuation of US$ 33.36 Million.
At what rate will the Coronary Stents market flourish from 2022 to 2032?
From 2022 to 2032, sales of Coronary Stents are expected to grow at a 5.1% CAGR.
What is the expected market value for Coronary Stents in 2032?
By 2032, Future Market Insights expects the Coronary Stents market to reach US$ 51.2 Million.
Table of Content
1. Executive Summary | Coronary Stents Market 2. Assumptions and Acronyms Used 3. Research Methodology 4. Market Introduction 4.1. Market Definition 4.2. Market Taxonomy 5. Market Analysis Scenario 5.1. Market Size (US$ Million) and Forecast 5.1.1. Market Size and Y-o-Y Growth 5.1.2. Absolute $ Opportunity 5.2. Market Overview 5.2.1. Value Chain 5.2.2. Epidemiology of Cardiovascular Diseases 5.2.3. Key Regulations and Reimbursement Scenario 5.2.4. PEST Analysis 6. Market Dynamics 6.1. Macro-economic Factors 6.2. Drivers 6.2.1. Supply Side 6.2.2. Demand Side 6.3. Restraints 6.4. Opportunity 6.5. Trends 7. Global Market Analysis and Forecast, By Product 7.1. Introduction 7.1.1. Basis Point Share (BPS) Analysis By Product 7.1.2. Y-o-Y Growth Projections By Product 7.2. Market Size (US$ Million) and Volume (Units) Forecast By Product 7.2.1. Drug Eluting Stent (DES) 7.2.2. Bare Metal Stent (BMS) 7.2.3. Bioresorbable Vascular Stent (BVS) 7.3. Global Market Attractiveness Analysis, By Product Type 8. Global Market Analysis and Forecast, By Raw Material 8.1. Introduction 8.1.1. Basis Point Share (BPS) Analysis By Raw Material 8.1.2. Y-o-Y Growth Projections By Raw Material 8.2. Market Size (US$ Million) Forecast By Raw Material 8.2.1. Cobalt Chromium 8.2.2. Stainless Steel 8.2.3. Platinum – Chromium 8.2.4. Nickel-Titanium 8.2.5. Polymer 8.3. Global Market Attractiveness Analysis, By Raw Material 9. Global Market Analysis and Forecast, By End User 9.1. Introduction 9.1.1. Basis Point Share (BPS) Analysis By End User 9.1.2. Y-o-Y Growth Projections By End User 9.2. Market Size (US$ Million) Forecast By End User 9.2.1. Hospitals 9.2.2. Ambulatory Surgical Centers 9.2.3. Cardiac Catheterization Laboratories 9.3. Market Attractiveness Analysis By End User 10. Global Market Analysis and Forecast, By Region 10.1. Introduction 10.1.1. Basis Point Share (BPS) Analysis By Region 10.1.2. Y-o-Y Growth Projections By Region 10.2. Market Size (US$ Million) Forecast By Region 10.2.1. North America 10.2.2. Latin America 10.2.3. Brazil 10.2.4. Western Europe 10.2.5. Eastern Europe 10.2.6. Asia Pacific Excluding Japan 10.2.7. Japan 10.2.8. Middle East and Africa (MEA) 10.3. Market Attractiveness Analysis By Region 11. North America Market Analysis and Forecast 11.1. Introduction 11.1.1. Basis Point Share (BPS) Analysis By Country 11.1.2. Y-o-Y Growth Projections By Country 11.2. Market Size (US$ Million) Forecast By Country 11.2.1. USA 11.2.2. Canada 11.3. Market Size (US$ Million) Forecast By Product 11.3.1. Drug Eluting Stent (DES) 11.3.2. Bare Metal Stent (BMS) 11.3.3. Bioresorbable Vascular Stent (BVS) 11.4. Market Size (US$ Million) Forecast By Raw Material 11.4.1. Cobalt Chromium 11.4.2. Stainless Steel 11.4.3. Platinum – Chromium 11.4.4. Nickel-Titanium 11.4.5. Polymer 11.5. Market Size (US$ Million) Forecast By End User 11.5.1. Hospitals 11.5.2. Ambulatory Surgical Centers 11.5.3. Cardiac Catheterization Laboratories 11.6. Market Attractiveness Analysis 11.6.1. By Country 11.6.2. By Product 11.6.3. By Raw Material 11.6.4. By End User 11.7. Prominent Trends 11.8. Drivers and Restraints: Impact Analysis 12. Latin America Market Analysis and Forecast 12.1. Introduction 12.1.1. Basis Point Share (BPS) Analysis By Country 12.1.2. Y-o-Y Growth Projections By Country 12.2. Market Size (US$ Million) and Volume (Units) Forecast By Country 12.2.1. Mexico 12.2.2. Argentina 12.2.3. Rest of Latin America 12.3. Market Size (US$ Million) Forecast By Product 12.3.1. Drug Eluting Stent (DES) 12.3.2. Bare Metal Stent (BMS) 12.3.3. Bioresorbable Vascular Stent (BVS) 12.4. Market Size (US$ Million) Forecast By Raw Material 12.4.1. Cobalt Chromium 12.4.2. Stainless Steel 12.4.3. Platinum - Chromium 12.4.4. Nickel-Titanium 12.4.5. Polymer 12.5. Market Size (US$ Million) Forecast By End User 12.5.1. Hospitals 12.5.2. Ambulatory Surgical Centers 12.5.3. Cardiac Catheterization Laboratories 12.6. Market Attractiveness Analysis 12.6.1. By Country 12.6.2. By Product 12.6.3. By Raw Material 12.6.4. By End User 12.7. Prominent Trends 12.8. Drivers and Restraints: Impact Analysis 13. Brazil Market Analysis and Forecast 13.1. Introduction 13.1.1. Basis Point Share (BPS) Analysis By Country 13.1.2. Y-o-Y Growth Projections By Country 13.2. Market Size (US$ Million) Forecast By Product 13.2.1. Drug Eluting Stent (DES) 13.2.2. Bare Metal Stent (BMS) 13.2.3. Bioresorbable Vascular Stent (BVS) 13.3. Market Size (US$ Million) Forecast By Raw Material 13.3.1. Cobalt Chromium 13.3.2. Stainless Steel 13.3.3. Platinum – Chromium 13.3.4. Nickel-Titanium 13.3.5. Polymer 13.4. Market Size (US$ Million) Forecast By End User 13.4.1. Hospitals 13.4.2. Ambulatory Surgical Centers 13.4.3. Cardiac Catheterization Laboratories 13.5. Market Attractiveness Analysis 13.5.1. By Product 13.5.2. By Raw Material 13.5.3. By End User 14. Western Europe Market Analysis and Forecast 14.1. Introduction 14.1.1. Basis Point Share (BPS) Analysis By Country / Region 14.1.2. Y-o-Y Growth Projections By Country 14.2. Market Size (US$ Million) and Volume (Units) Forecast By Country / Region 14.2.1. Germany 14.2.2. France 14.2.3. Italy 14.2.4. Spain 14.2.5. United Kingdom 14.2.6. BENELUX 14.2.7. Rest of Western Europe 14.3. Market Size (US$ Million) Forecast By Product 14.3.1. Drug Eluting Stent (DES) 14.3.2. Bare Metal Stent (BMS) 14.3.3. Bioresorbable Vascular Stent (BVS) 14.4. Market Size (US$ Million) Forecast By Raw Material 14.4.1. Cobalt Chromium 14.4.2. Stainless Steel 14.4.3. Platinum – Chromium 14.4.4. Nickel-Titanium 14.4.5. Polymer 14.5. Market Size (US$ Million) Forecast By End User 14.5.1. Hospitals 14.5.2. Ambulatory Surgical Centers 14.5.3. Cardiac Catheterization Laboratories 14.6. Market Attractiveness Analysis 14.6.1. By Country 14.6.2. By Product 14.6.3. By Raw Material 14.6.4. By End User 14.7. Prominent Trends 14.8. Drivers and Restraints: Impact Analysis 15. Eastern Europe Market Analysis and Forecast 15.1. Introduction 15.1.1. Basis Point Share (BPS) Analysis By Country 15.1.2. Y-o-Y Growth Projections By Country 15.2. Market Size (US$ Million) and Volume (Units) Forecast By Country 15.2.1. Russia 15.2.2. Poland 15.2.3. Rest of Eastern Europe 15.3. Market Size (US$ Million) Forecast By Product 15.3.1. Drug Eluting Stent (DES) 15.3.2. Bare Metal Stent (BMS) 15.3.3. Bioresorbable Vascular Stent (BVS) 15.4. Market Size (US$ Million) Forecast By Raw Material 15.4.1. Cobalt Chromium 15.4.2. Stainless Steel 15.4.3. Platinum – Chromium 15.4.4. Nickel-Titanium 15.4.5. Polymer 15.5. Market Size (US$ Million) Forecast By End User 15.5.1. Hospitals 15.5.2. Ambulatory Surgical Centers 15.5.3. Cardiac Catheterization Laboratories 15.6. Market Attractiveness Analysis 15.6.1. By Country 15.6.2. By Product 15.6.3. By Raw Material 15.6.4. By End User 15.7. Prominent Trends 15.8. Drivers and Restraints: Impact Analysis 16. Asia Pacific Excluding Japan (APEJ) Market Analysis and Forecast 16.1. Introduction 16.1.1. Basis Point Share (BPS) Analysis By Country / Region 16.1.2. Y-o-Y Growth Projections By Country / Region 16.2. Market Size (US$ Million) and Volume (Units) Forecast By Country / Region 16.2.1. China 16.2.2. India 16.2.3. ASEAN 16.2.4. Australia and New Zealand 16.2.5. Rest of Asia Pacific Excluding Japan 16.3. Market Size (US$ Million) Forecast By Product 16.3.1. Drug Eluting Stent (DES) 16.3.2. Bare Metal Stent (BMS) 16.3.3. Bioresorbable Vascular Stent (BVS) 16.4. Market Size (US$ Million) Forecast By Raw Material 16.4.1. Cobalt Chromium 16.4.2. Stainless Steel 16.4.3. Platinum – Chromium 16.4.4. Nickel-Titanium 16.4.5. Polymer 16.5. Market Size (US$ Million) Forecast By End User 16.5.1. Hospitals 16.5.2. Ambulatory Surgical Centers 16.5.3. Cardiac Catheterization Laboratories 16.6. Market Attractiveness Analysis 16.6.1. By Country 16.6.2. By Product 16.6.3. By Raw Material 16.6.4. By End User 16.7. Prominent Trends 16.8. Drivers and Restraints: Impact Analysis 17. Japan Market Analysis and Forecast 17.1. Introduction 17.2. Market Size (US$ Million) and Volume (Units) Forecast By Product 17.3. Market Size (US$ Million) Forecast By Product 17.3.1. Drug Eluting Stent (DES) 17.3.2. Bare Metal Stent (BMS) 17.3.3. Bioresorbable Vascular Stent (BVS) 17.4. Market Size (US$ Million) Forecast By Raw Material 17.4.1. Cobalt Chromium 17.4.2. Stainless Steel 17.4.3. Platinum – Chromium 17.4.4. Nickel-Titanium 17.4.5. Polymer 17.5. Market Size (US$ Million) Forecast By End User 17.5.1. Hospitals 17.5.2. Ambulatory Surgical Centers 17.5.3. Cardiac Catheterization Laboratories 17.6. Market Attractiveness Analysis 17.6.1. By Country 17.6.2. By Product 17.6.3. By Raw Material 17.6.4. By End User 17.7. Prominent Trends 17.8. Drivers and Restraints: Impact Analysis 18. MEA (Middle East & Africa) Market Analysis and Forecast 18.1. Introduction 18.1.1. Basis Point Share (BPS) Analysis By Country 18.1.2. Y-o-Y Growth Projections By Country 18.2. Market Size (US$ Million) and Volume (Units) Forecast By Country 18.2.1. GCC Countries 18.2.2. South Africa 18.2.3. North Africa 18.2.4. Rest of Middle East and Africa 18.3. Market Size (US$ Million) Forecast By Product 18.3.1. Drug Eluting Stent (DES) 18.3.2. Bare Metal Stent (BMS) 18.3.3. Bioresorbable Vascular Stent (BVS) 18.4. Market Size (US$ Million) Forecast By Raw Material 18.4.1. Cobalt Chromium 18.4.2. Stainless Steel 18.4.3. Platinum – Chromium 18.4.4. Nickel-Titanium 18.4.5. Polymer 18.5. Market Size (US$ Million) Forecast By End User 18.5.1. Hospitals 18.5.2. Ambulatory Surgical Centers 18.5.3. Cardiac Catheterization Laboratories 18.6. Market Attractiveness Analysis 18.6.1. By Country 18.6.2. By Product 18.6.3. By Raw Material 18.6.4. By End User 18.7. Prominent Trends 18.8. Drivers and Restraints: Impact Analysis 19. Competition Landscape 19.1. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments, Company Share Analysis) 19.2. Global Players 19.2.1. TERUMO CORPORATION 19.2.2. Boston Scientific Corporation 19.2.3. Medtronic 19.2.4. Vascular Concepts 19.2.5. B. Braun Melsungen AG 19.2.6. BIOTRONIK SE & Co. KG 19.2.7. Abbott Laboratories 19.2.8. Biosensors International Group, Ltd. 19.2.9. HEXACATH 19.2.10. STENTYS SA
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Value (US$ Million) Forecast By Product Type, 2022 to 2032 Table 02: Global Market Value (US$ Million) Forecast By Raw Material, 2022 to 2032 Table 03: Global Market Value (US$ Million) Forecast By End User, 2022 to 2032 Table 04: Global Market Value (US$ Million) Forecast By Region, 2022 to 2032 Table 05: North America Market Value (US$ Million) Forecast By Country, 2022 to 2032 Table 06: North America Market Value (US$ Million) Forecast By Product Type, 2022 to 2032 Table 07: North America Market Value (US$ Million) Forecast By Raw Material, 2022 to 2032 Table 08: North America Market Value (US$ Million) Forecast By End User, 2022 to 2032 Table 09: Latin America Excluding Brazil Market Value (US$ Million) Forecast By Country, 2022 to 2032 Table 10: Latin America Excluding Brazil Market Value (US$ Million) Forecast By Product Type, 2022 to 2032 Table 11: Latin America Excluding Brazil Market Value (US$ Million) Forecast By Raw Material, 2022 to 2032 Table 12: Latin America Excluding Brazil Market Value (US$ Million) Forecast By End User, 2022 to 2032 Table 13: Brazil Market Value (US$ Million) Forecast By Product Type, 2022 to 2032 Table 14: Brazil Market Value (US$ Million) Forecast By Raw Material, 2022 to 2032 Table 15: Brazil Market Value (US$ Million) Forecast By End User, 2022 to 2032 Table 16: Western Europe Market Value (US$ Million) Forecast By Country, 2022 to 2032 Table 17: Western Europe Market Value (US$ Million) Forecast By Product Type, 2022 to 2032 Table 18: Western Europe Market Value (US$ Million) Forecast By Raw Material, 2022 to 2032 Table 19: Western Europe Market Value (US$ Million) Forecast By End User, 2022 to 2032 Table 20: Eastern Europe Market Value (US$ Million) Forecast By Country, 2022 to 2032 Table 21: Eastern Europe Market Value (US$ Million) Forecast By Product Type, 2022 to 2032 Table 22: Eastern Europe Market Value (US$ Million) Forecast By Raw Material, 2022 to 2032 Table 23: Eastern Europe Market Value (US$ Million) Forecast By End User, 2022 to 2032 Table 24: APEJ Market Value (US$ Million) Forecast By Country, 2022 to 2032 Table 25: APEJ Market Value (US$ Million) Forecast By Product Type, 2022 to 2032 Table 26: APEJ Market Value (US$ Million) Forecast By Raw Material, 2022 to 2032 Table 27: APEJ Market Value (US$ Million) Forecast By End User, 2022 to 2032 Table 28: Japan Market Value (US$ Million) Forecast By Product Type, 2022 to 2032 Table 29: Japan Market Value (US$ Million) Forecast By Raw Material, 2022 to 2032 Table 30: Japan Market Value (US$ Million) Forecast By End User, 2022 to 2032 Table 31: MEA Market Value (US$ Million) Forecast By Country, 2022 to 2032 Table 32: MEA Market Value (US$ Million) Forecast By Product Type, 2022 to 2032 Table 33: MEA Market Value (US$ Million) Forecast By Raw Material, 2022 to 2032 Table 34: MEA Market Value (US$ Million) Forecast By End User, 2022 to 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Market Value (US$ Million) Forecast, 2016 to 2032 Figure 02: Global Market Absolute $ Opportunity, 2016 to 2032 Figure 03: Global Market Y-o-Y Growth, 2016 to 2032 Figure 04: Global Market Share Analysis (%) By Product Type, 2022 & 2032 Figure 05: Global Market Y-o-Y Growth (%) By Product Type, 2022 to 2032 Figure 06: Global Market Attractiveness Analysis By Product Type, 2022 to 2032 Figure 07: Global Market Absolute $ Opportunity (US$ Million) By Drug-Eluting Stent, 2022 to 2032 Figure 08: Global Market Absolute $ Opportunity (US$ Million) By Bare Metal Stent Segment, 2022 to 2032 Figure 09: Global Market Absolute $ Opportunity (US$ Million) By Bioresorbable Vascular Stent, 2022 to 2032 Figure 10: Global Market Share Analysis (%) By Raw Material, 2022 & 2032 Figure 11: Global Market Y-o-Y Growth (%) By Raw Material, 2022 to 2032 Figure 12: Global Market Attractiveness Analysis By Raw Material, 2022 to 2032 Figure 13: Global Market Absolute $ Opportunity (US$ Million) By Cobalt Chromium, 2022 to 2032 Figure 14: Global Market Absolute $ Opportunity (US$ Million) By Stainless Steel, 2022 to 2032 Figure 15: Global Market Absolute $ Opportunity (US$ Million) By Platinum – Chromium, 2022 to 2032 Figure 16: Global Market Absolute $ Opportunity (US$ Million) By Nickel – Titanium, 2022 to 2032 Figure 17: Global Market Absolute $ Opportunity (US$ Million) By Polymer, 2022 to 2032 Figure 18: Global Market Share Analysis (%) By End User, 2022 & 2032 Figure 19: Global Market Y-o-Y Growth (%) By End User, 2022 to 2032 Figure 20: Global Market Attractiveness Analysis By End User, 2022 to 2032 Figure 21: Global Market Absolute $ Opportunity (US$ Million) By Hospitals, 2022 to 2032 Figure 22: Global Market Absolute $ Opportunity (US$ Million) By Ambulatory Surgical Centers Segment, 2022 to 2032 Figure 23: Global Market Absolute $ Opportunity (US$ Million) By Cardiac Catheterization Laboratories, 2022 to 2032 Figure 24: Global Market Share Analysis (%) By Region, 2022 & 2032 Figure 25: Global Market Y-o-Y Growth (%) By Region, 2022 to 2032 Figure 26: Global Market Attractiveness Analysis By Region, 2022 to 2032 Figure 27: North American Market Absolute $ Opportunity (US$ Million), 2022 to 2032 Figure 28: Latin America Market Absolute $ Opportunity (US$ Million) By Latin America, 2022 to 2032 Figure 29: BrazilMarket Absolute $ Opportunity (US$ Million) By Brazil, 2022 to 2032 Figure 30: Western EuropeMarket Absolute $ Opportunity (US$ Million) By Western Europe, 2022 to 2032 Figure 31: Eastern Europe Stent Market Absolute $ Opportunity (US$ Million) By Eastern Europe, 2022 to 2032 Figure 32: APEJMarket Absolute $ Opportunity (US$ Million) By APEJ, 2022 to 2032 Figure 33: JapanMarket Absolute $ Opportunity (US$ Million) By Japan, 2022 to 2032 Figure 34: MEAMarket Absolute $ Opportunity (US$ Million) By MEA, 2022 to 2032 Figure 35: North America Share Analysis (%) By Country, 2022 & 2032 Figure 36: North America Attractiveness Analysis By Country, 2022 to 2032 Figure 37: North America Y-o-Y Growth (%) By Country, 2022 to 2032 Figure 38: North America Market Attractiveness Analysis By Product Type, 2022 to 2032 Figure 39: North America Market Attractiveness Analysis By Raw Material, 2022 to 2032 Figure 40: North America Market Attractiveness Analysis By End User, 2022 to 2032 Figure 41: Latin America Share Analysis (%) By Country, 2022 & 2032 Figure 42: Latin America Attractiveness Analysis By Country, 2022 to 2032 Figure 43: Latin America Y-o-Y growth (%) By Country, 2022 to 2032 Figure 44: Latin America Market Attractiveness Analysis By Product Type, 2022 to 2032 Figure 45: Latin America Market Attractiveness Analysis By Raw Material, 2022 to 2032 Figure 46: Latin America Market Attractiveness Analysis By End User, 2022 to 2032 Figure 47: Brazil Market Attractiveness Analysis By Product Type, 2022 to 2032 Figure 48: Brazil Market Attractiveness Analysis By Raw Material, 2022 to 2032 Figure 49: Brazil Market Attractiveness Analysis By End User, 2022 to 2032 Figure 50: Western Europe Share Analysis (%) By Country, 2022 & 2032 Figure 51: Western Europe Attractiveness Analysis By Country, 2022 to 2032 Figure 52: Western Europe Y-o-Y growth (%) By Country, 2022 to 2032 Figure 53: Western Europe Market Attractiveness Analysis By Product Type, 2022 to 2032 Figure 54: Western Europe Market Attractiveness Analysis By Raw Material, 2022 to 2032 Figure 55: Western Europe Market Attractiveness Analysis By End User, 2022 to 2032 Figure 56: Eastern Europe Share Analysis (%) By Country, 2022 & 2032 Figure 57: Eastern Europe Attractiveness Analysis By Country, 2022 to 2032 Figure 58: Eastern Europe Y-o-Y growth (%) By Country, 2022 to 2032 Figure 59: Eastern Europe Market Attractiveness Analysis By Product Type, 2022 to 2032 Figure 60: Eastern Europe Market Attractiveness Analysis By Raw Material, 2022 to 2032 Figure 61: Eastern Europe Market Attractiveness Analysis By End User, 2022 to 2032 Figure 62: APEJ Share Analysis (%) By Country, 2022 & 2032 Figure 63: APEJ Attractiveness Analysis By Country, 2022 to 2032 Figure 64: APEJ Y-o-Y growth (%) By Country, 2022 to 2032 Figure 65: APEJ Market Attractiveness Analysis By Product Type, 2022 to 2032 Figure 66: APEJ Market Attractiveness Analysis By Raw Material, 2022 to 2032 Figure 67: APEJ Market Attractiveness Analysis By End User, 2022 to 2032 Figure 68: Japan Market Attractiveness Analysis By Product Type, 2022 to 2032 Figure 69: Japan Market Attractiveness Analysis By Raw Material, 2022 to 2032 Figure 70: Japan Market Attractiveness Analysis By End User, 2022 to 2032 Figure 71: MEA Share Analysis (%) By Country, 2022 & 2032 Figure 72: MEA Attractiveness Analysis By Country, 2022 to 2032 Figure 73: MEA Y-o-Y growth (%) By Country, 2022 to 2032 Figure 74: MEA Market Attractiveness Analysis By Product Type, 2022 to 2032 Figure 75: MEA Market Attractiveness Analysis By Raw Material, 2022 to 2032 Figure 76: MEA Market Attractiveness Analysis By End User, 2022 to 2032
Recommendations
Explore Healthcare Insights
View Reports
